Trial Profile
Gemcitabine and Oxaliplatin in the treatment of locally advanced or metastatic transitional cell carcinoma of the urinary tract in patients with impaired renal function and patients who have progressed on a cisplatin-based regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 17 Jul 2017 New trial record